Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Poly(ADP-ribose) polymerase-1 (
PARP-1
) is a NAD-consuming enzyme with an emerging key role in epigenetic regulation of gene transcription. Although
PARP-1
expression is characteristically restricted to the nucleus, a few studies report the mitochondrial localization of the enzyme and its ability to regulate organelle functioning. Here, we show that, despite exclusive nuclear localization of
PARP-1
, mitochondrial homeostasis is compromised in cell lines exposed to
PARP-1
pharmacological inhibitors or small interfering RNA.
PARP-1
suppression reduces integrity of mitochondrial DNA (mtDNA), as well as expression of mitochondria-encoded respiratory complex subunits COX-1, COX-2, and ND-2. Accordingly,
PARP-1
localizes at promoters of nuclear genes encoding both the mtDNA repair proteins UNG1,
MYH1
, and APE1 and the mtDNA transcription factors TFB1M and TFB2M. It is noteworthy that poly(ADP-ribosyl)ation is required for nuclear gene expression of these mitochondrial proteins. Consistent with these findings,
PARP-1
suppression impairs mitochondrial ATP production. Our results indicate that
PARP-1
plays a central role in mitochondrial homeostasis by epigenetically regulating nuclear genes involved in mtDNA repair and transcription. These data might have important implications in pharmacology of
PARP-1
inhibitors as well as clinical oncology and aging.
...
PMID:Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription. 2144